Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Frontiers in Oncology|March 20, 2018
Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic MelanomaJohn E Mullinax, MacLean Hall, Sangeetha Prabhakaran, et al.
Molecular Cancer Therapeutics|June 24, 2025
PV-10 triggers immunogenic cell death in head and neck squamous cell carcinoma via endoplasmic reticulum stress and apoptosisSowjanya Thatikonda, Ritu Chaudhary, Yeva Meshkovska, et al.
Oncoimmunology|September 20, 2018
Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancerMichael Poch, MacLean Hall, Autumn Joerger, et al.
Molecular Cancer Therapeutics|April 24, 2024
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0Joseph Markowitz, Michael Shamblott, Andrew S Brohl, et al.
Nature Communications|August 19, 2020
T-cells produce acidic niches in lymph nodes to suppress their own effector functionsHao Wu, Veronica Estrella, Matthew Beatty, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 7, 2021
Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathwayYongsheng Jia, Krithika N Kodumudi, Ganesan Ramamoorthi, et al.
Cytotherapy|April 7, 2024
Accelerating the development of genetically engineered cellular therapies: a framework for extrapolating data across related productsMark D Stewart, Michael Kalos, Vicki Coutinho, et al.
Cancer Immunology Research|April 18, 2025
Antitumor CD4+ T Helper 1 Cells Target and Control the Outgrowth of Disseminated Cancer CellsGanesan Ramamoorthi, Marie Catherine Lee, Carly M Farrell, et al.
Journal of Clinical Virology Plus|September 1, 2023
SARS-CoV-2 antibody response duration and neutralization following natural infectionChristopher W Dukes, Renata Am Rossetti, Jonathan A Hensel, et al.
Vaccines|January 22, 2024
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer PatientsChristopher W Dukes, Marine Potez, Jeffrey Lancet, et al.
Pageof 10